Director, Key Accounts (Central Region) jobs in United States
cer-icon
Apply on Employer Site
company-logo

QIAGEN · 22 hours ago

Director, Key Accounts (Central Region)

QIAGEN is a global leader in science and healthcare, dedicated to making improvements in life possible. The Key Account Regional Leader will drive regional growth and expand enterprise partnerships across the Central Region, leading a team responsible for enterprise-level account ownership and execution.

BiotechnologyHealth CareHealth DiagnosticsPrecision Medicine
Hiring Manager
Daniel Nguyen
linkedin

Responsibilities

Own and execute QIAGEN’s Central Region enterprise account strategy across IDN, hospital system, and Clinical Life Science customers
Lead, coach, and develop a team of HSEs and KAMs, fostering a culture of strategic thinking, collaboration, and performance excellence
Drive portfolio-level growth through enterprise contracting, menu expansion, automation, and workflow optimization aligned to customer priorities
Ensure each account leader delivers robust, data-driven enterprise account plans that expand share of wallet and deepen long-term partnerships
Translate national strategy into clear regional priorities with disciplined execution
Serve as the regional enterprise quarterback, ensuring aligned engagement across Molecular Diagnostics, QuantiFERON, Genomics, Automation, and Clinical Life Science portfolios
Partner closely with Marketing, Scientific Affairs, Medical Affairs, Operations, Supply Chain, Finance, and Commercial Operations
Establish clear expectations for collaboration, governance, and execution across all customer-facing teams
Drive portfolio-wide alignment so customers experience consistent messaging, value delivery, and execution excellence
Lead and support teams through complex enterprise negotiations, including multi-year agreements, pricing structures, volume commitments, and rebate frameworks
Provide regional oversight of forecasting accuracy, profitability, and contractual compliance
Ensure disciplined, value-based selling practices across all enterprise accounts
Escalate and resolve commercial, operational, or contractual risks impacting key customers
Maintain deep understanding of regional healthcare dynamics, clinical laboratory operations, and clinical life science workflows
Guide teams to anticipate evolving customer needs and proactively position QIAGEN solutions
Identify regional market trends and competitive threats, translating insight into strategic action
Lead by example through direct engagement with senior customer executives and regional decision-makers
Support teams through joint field travel, executive sponsorship, and high-impact customer reviews
Maintain strong visibility with internal leadership and cross-functional partners
Reinforce a culture of high-touch engagement, accountability, and operational rigor

Qualification

Life SciencesDiagnosticsClinical Life SciencesEnterprise ContractingPCRNGSAutomationSyndromic TestingEnterprise Lab WorkflowsExecutive InfluenceLeadershipCommunication

Required

Bachelor's degree in Life Sciences, Business, or related field required
10+ years of experience in diagnostics, healthcare, or clinical life sciences, including 5+ years leading enterprise or strategic account teams
Proven success leading HSEs, KAMs, or equivalent enterprise sales roles
Strong commercial and technical acumen across diagnostics and clinical life sciences, including PCR, NGS, automation, syndromic testing, and enterprise lab workflows
Demonstrated expertise in complex enterprise contracting and portfolio-based selling
Exceptional leadership, communication, and executive-level influencing skills
Willingness to travel extensively within the Central Region (up to 75%)

Preferred

Advanced degree preferred

Benefits

Bonus/Commission
Local benefits
Referral Program
Volunteer Day
Internal Academy (QIALearn)
Employee Assistance Program
Hybrid work (conditional to your role)

Company

QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions.

Funding

Current Stage
Public Company
Total Funding
$754M
2025-08-28Post Ipo Debt· $750M
2022-04-04Acquired
2021-10-22Grant· $4M

Leadership Team

D
Dan Richards
VP Biomedical Informatics & Ingenuity
linkedin
leader-logo
Lilly Kong
Sr. Director, Assay Development
linkedin
Company data provided by crunchbase